Non-surgical Periodontal Therapy Effects Metabolic Control in Diabetics
Evaluation of Effect of Nonsurgical Periodontal Therapy on Metabolic Control in Patients With Type II Diabetes
1 other identifier
interventional
40
1 country
1
Brief Summary
The purpose of this study is to determine whether nonsurgical periodontal therapy is effective in the metabolic control of patients with type II Diabetes mellitus.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_2
Started Jun 2007
Shorter than P25 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
December 1, 2010
CompletedFirst Posted
Study publicly available on registry
December 2, 2010
CompletedApril 8, 2015
April 1, 2015
1.3 years
December 1, 2010
April 7, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolic control
fasting plasma glucose (FPG), HbA1c, TG, TC, high density lipoprotein cholesterol (HDL), and LDL are measured at baseline and 3 months after treatment.
3 months after treatment
Secondary Outcomes (1)
periodontal improvement after scaling and rootplaning
3 months after treatment
Study Arms (2)
Scalig and Rootplaning
ACTIVE COMPARATORpatients will receive scaling and root planing therapy
control
NO INTERVENTIONpatients in control group will not receive periodontal treatment in the time period of the study
Interventions
All patients in the test group receive scaling and rootplaning under local anesthesia
Eligibility Criteria
You may qualify if:
- (1) mild to moderate periodontitis according to the criteria of the American Academy of Periodontology (32); (2) diagnosis of DM2 with glycated hemoglobin (HbA1c) values over 7%; (3) no major diabetic complications; (4) blood sugar controlled with glybenclamide and metformin, without insulin administration; and (5) no systemic antibiotic administration or periodontal treatment within the last 6 months.
You may not qualify if:
- (1) presence of systemic diseases other than DM2 that may influence the course of periodontal disease; (2) intake of immunosuppressive drugs, steroids, hydantoin, or non-steroidal anti-inflammatory drugs; (3) tobacco use; (4) pregnancy or intention to become pregnant during the study period; (5) fixed orthodontic appliances; and (5) refusal or inability to give informed consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mashhad Dental School, Mashhad University of Medical Sciences
Mashhad, Khorasan Razavi, 91735-984, Iran
Related Publications (1)
Moeintaghavi A, Arab HR, Bozorgnia Y, Kianoush K, Alizadeh M. Non-surgical periodontal therapy affects metabolic control in diabetics: a randomized controlled clinical trial. Aust Dent J. 2012 Mar;57(1):31-7. doi: 10.1111/j.1834-7819.2011.01652.x.
PMID: 22369555RESULT
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Amir Moeintaghavi, DDS.,Ms.
Associate professor,Mashhad Dental School, Mashhad University of Medical Sciences
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- associate professor of periodontics
Study Record Dates
First Submitted
December 1, 2010
First Posted
December 2, 2010
Study Start
June 1, 2007
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
April 8, 2015
Record last verified: 2015-04